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Abstract
Background: An important determinant of pregnancy outcome is the timely onset of labor and birth. Prolonged
gestation complicates 5% to 10% of all pregnancies and confers increased risk to both the fetus and mother. The
purpose of this review was to study the possible impact of induction of labour (IOL) for post-term pregnancies
compared to expectant management on stillbirths.
Methods: A systematic review of the published studies including randomized controlled trials, quasi- randomized
trials and observational studies was conducted. Search engines used were PubMed, the Cochrane Library, the WHO
regional databases and hand search of bibliographies. A standardized data abstraction sheet was used.
Recommendations have been made for input to the Lives Saved Tool (LiST) model by following standardized
guidelines developed by the Child Health Epidemiology Reference Group (CHERG).
Results: A total of 25 studies were included in this review. Meta-analysis of 14 randomized controlled trials (RCTs)
suggests that a policy of elective IOL for pregnancies at or beyond 41 weeks is associated with significantly fewer
perinatal deaths (RR=0.31; 95% CI: 0.11-0.88) compared to expectant management, but no significant difference in
the incidence of stillbirth (RR= 0.29; 95% CI: 0.06-1.38) was noted. The included trials evaluating this intervention
were small, with few events in the intervention and control group. There was significant decrease in incidence of
neonatal morbidity from meconium aspiration (RR = 0.43, 95% CI 0.23-0.79) and macrosomia (RR = 0.72; 95% CI:
0.54 – 0.98). Using CHERG rules, we recommended 69% reduction as a point estimate for the risk of stillbirth with
IOL for prolonged gestation (> 41 weeks).
Conclusions: Induction of labour appears to be an effective way of reducing perinatal morbidity and mortality
associated with post-term pregnancies. It should be offered to women with post-term pregnancies after discussing
the benefits and risks of induction of labor.
Background
An important determinant of the pregnancy outcome is
the timely onset of labor and birth. Both preterm and
post-term births are associated with unfavorable mater-
nal and neonatal outcomes. Prolonged gestation compli-
cates 5% to 10% of all pregnancies and confers increased
risk to both the fetus and mother [1,2]. In the United
States, about 18% of all singleton pregnancies persist
beyond 41 weeks, 10% (range, 3% to 14%) continue
beyond 42 weeks and 4% (range, 2% to 7%) continue
beyond 43 completed weeks in the absence of an obste-
tric intervention [2,3]. Post-term pregnancy is associated
with higher rates of stillbirth, macrosomia (birth weight
>4000gm), birth injury and meconium aspiration syn-
drome [2]. The major cause of perinatal morbidity and
mortality in post-term pregnancy is presumed to be the
progressive uteroplacental insufficiency [4,5].
Many studies have assessed the gestation-specific still-
birth rate which is expressed as the number of stillbirths
per 1000 total births at each week of gestation. Divon
and colleagues [6] conducted a retrospective analysis of
all deliveries in Sweden from 1987 to 1992. They found a
statistically significant increase in the odds ratio for fetal
death from 41 weeks and beyond. Using fetal mortality at
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any medium, provided the original work is properly cited.40 weeks’ gestation as a reference level, the odds ratios
for fetal death were 1.5, 1.8, and 2.9 at 41, 42, and
43 weeks, respectively. Perinatal mortality (defined as
stillbirths plus early neonatal deaths) at 42 weeks of
gestation was twice that at 40 weeks (4 to 7 vs. 2 to 3 per
1000 deliveries, respectively) and increases 4-fold at
43 weeks and 5- to 7-fold at 44 weeks [3,7-9].
Currently there are no tests available to ascertain
whether it would be better to continue with the preg-
nancy or to induce birth, or tests that can determine the
best possible time for induction [10]. The Society of
Obstetricians and Gynecologists of Canada Clinical
Practice Guidelines proposed induction of labour
between 41 and 42 weeks of gestation [11]. Previously
some authors believed that the policy of IOL between
41-42 weeks was a crude approach for reducing stillbirth
rates because even though the risk of fetal death is
increased post-term, many more fetal deaths occur
between 37 and 42 weeks than do so beyond 42 weeks
[12,13]. However available evidence from clinical trials
and systematic reviews do suggest an impact of induc-
tion of labour on perinatal mortality. [14].
The purpose of this review was to assess the impact of
elective induction of labour for post-term pregnancies
(> 41 weeks) of gestation on stillbirths compared to
expectant management (policy of awaiting spontaneous
onset of labour). This paper is part of a series of papers
which seek to estimate effect of an intervention for
input into the Lives Saved Tool (LiST) model [15]. An
intervention is currently included in the Lives Saved
Tool (LiST) model if there is evidence that it reduces
maternal mortality, infant/child mortality (<5 years)
and/or stillbirths. The process of generating recommen-
dations for an intervention involve qualitative evaluation
of available evidence according to adapted GRADE cri-
teria [16] and quantitative evaluation according to Child
Health Epidemiology Reference Group (CHERG) rules
[15]. For more details of the review methods, the
adapted GRADE approach, see the methods section and
the CHERG method paper [15].
Methods
Literature search
A literature search was conducted using search engines
like PubMed, the Cochrane Library and the WHO
regional databases. We identified all studies that com-
pared the impact of elective induction of labour versus
expectant management, for pregnancies at or beyond
41weeks of gestation, on stillbirths and perinatal mortal-
ity (figure 1). Furthermore, hand search of bibliographies
of relevant reviews was performed. Experts in the field
were contacted for further data or for unpublished trials.
We also looked at previous reviews for studies that
reported outcomes on morbidities associated with
prolonged pregnancy. Morbidities considered in our
review include meconium aspiration syndrome, birth
asphyxia, and macrosomia. The following search strategy
was used:
(“Pregnancy, Prolonged”[Mesh] OR “Labor, Induced”[-
M e s h ]O Ri n d u c t i o n )A N D( “Labor, Obstetric”[Mesh]
OR labor) AND ("Stillbirth”[Mesh] OR “Perinatal Mor-
tality”[Mesh] OR “Fetal Death”[Mesh] OR Stillbirth* OR
“Intrauterine death*” OR “perinatal mortality”).
For the initial selection, there was no restriction with
respect to the language of the article. However, non-
English articles were not translated and if the desired
information was available in the abstracts then those
were used. If full texts could not be retrieved relevant
available information was used from the abstract.
Inclusion criteria
￿All studies that were included in our review looked at
the impact of elective induction of labour for pregnan-
cies at or beyond 41 weeks on stillbirths or perinatal
mortality.
￿ The study designs selected were randomized con-
trolled trials, quasi experimental studies and observa-
tional studies.
￿ The eligible studies were those that compared the
impact of labour induction with expectant management.
￿Only those studies were included that evaluated low
risk pregnancies i.e. uncomplicated, singleton, and live
pregnancies at or beyond 41 completed weeks of
gestation.
￿ Selected studies clearly documented the outcome
data on stillbirth and/or perinatal mortality.
￿ The selected studies could differ in terms of the
methods of induction used and/or the techniques used
for monitoring of pregnancies that were managed
expectantly.
￿ Only data from RCTs were included in the meta-
analyses.
Exclusion criteria
￿
Studies investigating the impact of induction of labour
prior to 41 completed weeks on stillbirth and/or perina-
tal mortality were excluded.
￿
Studies that looked at induction of labour for reasons
other than prolonged gestation such as macrosomia etc.
were excluded.
￿
Studies that included complicated or high-risk pregnan-
cies were excluded.
￿
Studies comparing different methods of labour induction
(means no control group with expectant management) or
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42 weeks were excluded.
Validity assessment
We graded the ‘overall’ quality of evidence of an out-
come according to the CHERG adaptation of the
GRADE technique [16]. This technique is based on the
following components 1) the volume and consistency of
the evidence; 2) precision of the effect size or risk ratio;
and 3) the level of statistical evidence for an association
between the intervention and outcome, as reflected by
the p-value [15,16]. The individual studies were also
graded into ‘high’, ‘moderate’, ‘low’ and ‘very low’.
Studies were graded ‘high’ i fi tw e r ear a n d o m i z e do r
cluster randomized trial. The grade was then decreased
by one for each study design limitation. The grade was
increased by 1-2 for studies reporting a statistically sig-
nificant level of impact (>80% reduction) or an intent-
to-treat analysis. A study with a final grade of very low
was excluded based on inadequate quality. For more
details of the review methods, the adapted GRADE
approach or the LiST model see other articles in this
supplement.
Data abstraction
Two researchers’ extracted data into a standard web
excel sheet designed by the CHERG/LiST review group
[15]. The variables included were, for example, location
and setting of the study, its design and limitations, allo-
cation concealment, blinding assessment, rates of lost to
follow-up, intention-to-treat analysis, definitions of
intervention and control group.
Quantitative data synthesis
The study design considered for meta-analyses included
randomized controlled trials only. Meta-analyses were
generated using Generic Inverse Variance method of
meta-analysis [17]. Quasi-randomized trials and observa-
tional studies were also considered for this review, but
not included in meta-analyses. The definitions of still-
birth and perinatal mortality were taken as defined by
Numberofstudiesidentified
(n=1044)
Recordsexcluded
(n=913)
FullͲtextarticlesassessedfor
eligibility(n=131)
FullͲtextarticlesexcluded
(n=106)
Recordsscreened
(n=1044)
2studies
reporteddata
onbirth
asphyxia
7studiesreported
dataonmeconium
aspirationsyndrome
14studiesreported
dataonperiͲnatal
mortality
7studies
reporteddata
onMacrosomia
14studiesreported
dataonstillbirths
Studiesincludedinthe
review
(n=25)
Figure 1 Flow diagram showing identification of studies evaluating induction of labor at or beyond 41 weeks.
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ratios along with 95% confidence intervals. Fixed models
were used for primarily analyses. Statistical heterogene-
ity among trials was assessed by observing the overlap
of the confidence intervals among the studies, Chi
square value (P-value) of heterogeneity I
2 statistics.
A p value > 0.1 or I
2 value > 50% was taken to represent
substantial heterogeneity and random models were
used [18].
Results
Trial flow
The search strategy identified a total of 1044 records
(Fig 1). After initial screening of the titles and abstracts,
we selected 131 papers for data on the outcome mea-
sures of interest. A total of 25 relevant papers have been
included in the final database. The pertinent characteris-
tics of all included studies are given in Additional files 1,
2 and 3. The detailed data extraction with the limitation
of studies is shown in Additional File 4.
Results of the meta-analyses
There were 16 RCTs [19-34] and 3 quasi-experimental
studies [35-37] reporting outcome measures of interest.
Our meta-analyses of RCTs demonstrated that elective
IOL for post-term pregnancies at or beyond 41 weeks,
has a statistically significant impact on reducing perina-
tal mortality (RR=0.31 95% CI 0.11-0.88), but the impact
on stillbirth failed to reach a level of statistical signifi-
cance (RR= 0.29; 95% CI: 0.06-1.38) (figures 2 and 3
respectively). We also calculated number needed to treat
(NNT) for perinatal mortality (328 to reduce one case)
and stillbirths (657 to avoid one stillbirth). A subgroup
analysis for IOL at 41 completed weeks (based on
12 RCTs) showed a statistically significant impact on
perinatal mortality (RR=0.27 95% CI 0.08-0.98), while
the impact on stillbirth remained statistically insignifi-
cant (RR=0.29 95%CI 0.06-1.38) (data not shown). The
results of IOL at 42 weeks based on 2 RCTs showed a
statistically insignificant impact on perinatal mortality
(RR=0.41 95% CI 0.06-2.73), while the impact on still-
birth was not estimable since both the studies reported
zero estimates for stillbirth.
Data on morbidities associated with post-term preg-
nancy were presented in 10 trials [20-25,28,30,32,33]
that met our eligibility criteria. We conducted meta-
analyses to assess the impact of IOL at or beyond 41
weeks on meconium aspiration syndrome, birth
asphyxia, and macrosomia. Our analyses demonstrated a
statistically significant reduction in the incidence of
meconium aspiration syndrome (RR=0.43 95% CI 0.23-
0.79) (figure 4) based on seven studies and macrosomia
(RR=0.72 95% CI 0.54-0.98) (figure 5) also based on
seven trials. The impact on birth asphyxia (RR=1.86 95%
CI 0.51-6.76; 2 trials) (figure 6) failed to reach a level of
statistical significance.
Evidence from quasi-experimental studies
Three quasi randomized trials have been included in our
study [35-37]. One study comprising of 363 women was
c o n d u c t e di nU n i t e dK i n g d o mo v e rap e r i o do f
21 months. The women were allocated for either IOL
(n=195) at 290 days of gestation or expectant manage-
ment (n=207). The study reported one neonatal death in
the induced arm and one stillbirth in the expectant arm
[35]. Another prospective study was under taken from
September 2000 to September 2001 in Sobhraj mater-
nity hospital in Karachi, Pakistan [36]. This included a
total of 100 prolonged uncomplicated pregnancies.
Labour was induced in 50 patients at 294 days of gesta-
tion while the remaining 50 were managed expectantly.
Different methods of induction were used. The choice
of method depended on whether or not the cervix was
favorable. The study reported a total of 9 perinatal
deaths. Perinatal mortality was twice more in the con-
trolled group (5 stillbirths and 1 neonatal death) as
compared to the intervention group (2 stillbirths and 1
neonatal death). The difference in perinatal mortality
between the two groups was reported as being signifi-
cant (P≤ 0.05) [36]. A third study comprising of 156
uncomplicated post-date pregnancies was conducted.
The study group comprised of 78 patients who were
managed expectantly and the control group consisted of
78 women who were induced labour on day 294 of
gestation. This study reported one neonatal death due
to severe congenital heart disease in the expectant
group and one neonatal death due to asphyxia in the
induced group [37].
Evidence from observational studies
Six relevant observational studies were identified [38-43].
Two of these were prospective studies. One prospective
study of 395 singletons, uncomplicated post-term preg-
nancies was conducted at Queen Alia Military Hospital,
Jordan from January 2001 to July 2002 [38]. The study
comprised of two groups, one group being managed by
IOL (n=175) while the other was managed expectantly
(n=220). Labour was induced by inserting dinoprostone
3 mg vaginal pessaries in the posterior vaginal fornix.
Continuous fetal heart rate monitoring was done in both
groups. The study reported no statistically significant dif-
ferences in the fetal/ neonatal outcome measures
between the two groups. There were no perinatal deaths
in either groups (P=0.69) [38]. Another study addressed
the effect of induced labor using pitocin IV drip in
decreasing the incidence of perinatal complications and
perinatal mortality of prolonged pregnancy [39]. Induced
labor was used in a study group comprising of 126
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The control group had 128 prolonged, nulliparous and
uncomplicated pregnancies that were managed expec-
tantly. The perinatal mortality was 0 in the study group
and 3.1% in the control group. Also, the asphyxia rate
was 8.7% in the study group and 13.3% in the control.
The percentage of caesarean deliveries was the same in
both groups. The results of this study suggest that
induced labor is safe, effective and practical in the man-
agement of prolonged pregnancies [39].
The remaining 4 studies were retrospective studies.
One study compared the outcome of expectant manage-
ment of post-term pregnancy with active management
in Masaryk University, Brno [41]. The study comprised
of two groups. Group I included 1906 women, who
were managed actively by IOL in the 41
st week. Group
II included 2008 parturients who were managed expec-
tantly till the end of the 42
nd week at which labour was
induced. The study reported no differences in perinatal
mortality and morbidity between the two groups and
Study or Subgroup
1.2.2 41 completed weeks
Augensen 1987
Chanrachkul 2003
Dyson 1987
Gelisen 2005
Hannah 1992
Heimstad 2007
Henry 1969
James 2001
Martin 1989
NICHHD 1994
Sahraoui 2005
Suikkari 1983
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.13, df = 5 (P = 1.00); I² = 0%
Test for overall effect: Z = 1.99 (P = 0.05)
1.2.3 42 completed weeks
Bergsjo 1989
Herabutya 1992
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.06, df = 1 (P = 0.80); I² = 0%
Test for overall effect: Z = 0.92 (P = 0.36)
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.31, df = 7 (P = 1.00); I² = 0%
Test for overall effect: Z = 2.19 (P = 0.03)
Test for subgroup differences: Not applicable
Events
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
1
Total
214
124
152
300
1701
254
55
37
12
174
75
66
3164
94
57
151
3315
Events
0
0
1
1
2
1
2
0
0
0
1
0
8
2
1
3
11
Total
195
125
150
300
1706
254
57
37
10
175
75
53
3137
94
51
145
3282
Weight
10.4%
10.3%
17.2%
10.3%
16.9%
10.3%
75.4%
13.8%
10.9%
24.6%
100.0%
M-H, Fixed, 95% CI
Not estimable
Not estimable
0.33 [0.01, 8.01]
0.33 [0.01, 8.15]
0.20 [0.01, 4.18]
0.33 [0.01, 8.14]
0.21 [0.01, 4.22]
Not estimable
Not estimable
Not estimable
0.33 [0.01, 8.05]
Not estimable
0.27 [0.08, 0.98]
0.50 [0.05, 5.42]
0.30 [0.01, 7.18]
0.41 [0.06, 2.73]
0.31 [0.11, 0.88]
Induction Expectant Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 2 Induction of labour versus expectant management; Outcome: perinatal death.
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tant management of the post-term pregnancies to be
dangerous [41]. Similar conclusion was drawn by a ret-
rospective analysis comparing the outcomes of post-
term pregnancies managed actively by labour inductions
beginning at 42 weeks with expectant management of
labour [40]. The induced group comprised of 185
women while the group with spontaneous onset of
labour had 119 women. One stillbirth occurred in both
groups. There was also no statistical difference in the
maternal or fetal morbidity between the two groups
thus suggesting that standard clinical management is
sufficient to assure optimal perinatal outcome in post-
term pregnancies [40].
A study conducted in Canada assessed changes in the
rates of labour induction in post-term pregnancies and
its effects on the rates of stillbirth and cesarean section
during1980-1995 [42]. This study demonstrated a signif-
icant increase in the rates of labour induction among
women delivering at 41 or more weeks’ g e s t a t i o ni na l l
Study or Subgroup
2.2.2 41 completed weeks
Augensen 1987
Chanrachkul 2003
Dyson 1987
Gelisen 2005
Hannah 1992
Heimstad 2007
Henry 1969
James 2001
Martin 1989
NICHHD 1994
Sahraoui 2005
Suikkari 1983
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.08, df = 3 (P = 0.99); I² = 0%
Test for overall effect: Z = 1.56 (P = 0.12)
2.2.3 42 completed weeks
Bergsjo 1989
Herabutya 1992
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.08, df = 3 (P = 0.99); I² = 0%
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Not applicable
Events
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total
214
124
152
300
1701
254
55
37
12
174
75
66
3164
94
57
151
3315
Events
0
0
0
1
2
0
1
0
0
0
1
0
5
0
0
0
5
Total
195
125
150
300
1706
254
57
37
10
175
75
53
3137
94
51
145
3282
Weight
21.5%
35.8%
21.1%
21.5%
100.0%
100.0%
M-H, Fixed, 95% CI
Not estimable
Not estimable
Not estimable
0.33 [0.01, 8.15]
0.20 [0.01, 4.18]
Not estimable
0.35 [0.01, 8.30]
Not estimable
Not estimable
Not estimable
0.33 [0.01, 8.05]
Not estimable
0.29 [0.06, 1.38]
Not estimable
Not estimable
Not estimable
0.29 [0.06, 1.38]
Induction Expectant Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 3 Induction of labour versus expectant management; Outcome: stillbirth.
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among deliveries at 41 or more weeks’ gestation
decreased significantly, from 2.8 per 1000 total births in
1980 to 0.9 per 1000 total births in 1995 (p < 0.001).
The study concluded that the increased rate of labour
induction at 41 or more weeks’ gestation may have con-
tributed to the decreased stillbirth rates [42]. An obser-
vational study compared the impact of IOL with
spontaneous onset of labour among post term pregnan-
cies (> or = 294 days) between July 1980 -December
1984 at Chicago Lying-In Hospital. The study comprised
of 12,930 deliveries from which 707 gestations were pro-
longed (5.5%). Labor started spontaneously in 62%, and
38% underwent induction; the perinatal mortality was
20.5/1000 among those with spontaneous onset of labor
while no deaths occurred among those in whom labour
was induced. The study concluded that prolonged gesta-
tion had a high perinatal morbidity and mortality rate
and “active management” (induction at 42 weeks)
prevented perinatal deaths in this group thereby justify-
ing an active approach for post-term pregnancies [43].
Discussion
Meta-analyses of randomized controlled trials demon-
strate that a policy of induction of labour for pregnancies
at or beyond 41 weeks as compared to expectant man-
agement of gestation is associated with fewer perinatal
deaths, but no significant difference in the rate of still-
birth. The above mentioned results are in accordance to
the findings of the Cochrane review by Gulmezoglu et al
2009 [10]. This review included a total of 12 trials and
reported a non-significant reduction in stillbirth risk
(RR = 0.28, 95% CI: 0.05–1.67), but a statistically signifi-
cant reduction in perinatal mortality (RR = 0.30, 95% CI:
0.09–0.99). An update of this Cochrane review having 14
trials reports similar results [Stillbirth: 41 complete
weeks (RR = 0.29; 95% CI: 0.06 – 1.38), 42 complete
weeks (not estimable); perinatal death: 41 complete
Study or Subgroup
1.5.1 41 completed weeks
Dyson 1987
Gelisen 2005
Heimstad 2007
James 2001
NICHHD 1994
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 2.40, df = 4 (P = 0.66); I² = 0%
Test for overall effect: Z = 2.69 (P = 0.007)
1.5.2 42 completed weeks
Bergsjo 1989
Witter 1987
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.96, df = 1 (P = 0.33); I² = 0%
Test for overall effect: Z = 0.81 (P = 0.42)
Total (95% CI)
Total events
Heterogeneity: Chi² = 3.89, df = 6 (P = 0.69); I² = 0%
Test for overall effect: Z = 2.72 (P = 0.007)
Test for subgroup differences: Not applicable
Events
0
4
2
1
1
8
4
2
6
14
Total
152
300
254
37
174
917
94
103
197
1114
Events
6
12
2
2
2
24
8
1
9
33
Total
150
300
254
37
175
916
94
97
191
1107
Weight
19.5%
35.7%
6.0%
6.0%
5.9%
73.1%
23.8%
3.1%
26.9%
100.0%
M-H, Fixed, 95% CI
0.08 [0.00, 1.34]
0.33 [0.11, 1.02]
1.00 [0.14, 7.04]
0.50 [0.05, 5.28]
0.50 [0.05, 5.50]
0.35 [0.16, 0.75]
0.50 [0.16, 1.60]
1.88 [0.17, 20.44]
0.66 [0.24, 1.81]
0.43 [0.23, 0.79]
Induction Expectant Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 4 Induction of labour versus expectant management; Outcome: Meconium Aspiration Syndrome.
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Page 7 of 12weeks (RR = 0.27; 95% CI: 0.08 – 0.98), 42 complete
weeks (RR = 0.41; 95% CI: 0.06 – 2.73) (Gulmezoglu M
and Middleton P 2010, personal communication). The
Cochrane review also included trials that compared the
impact of IOL with expectant management between
37-40 completed weeks. In our review we have focused
only on pregnancies at or beyond 41 weeks. This is based
on the fact that most of the complications of prolonged
pregnancy are known to increase beyond this gestational
age [1,6,8,44,45]. Our review also includes data from
quasi experimental studies and observational studies and
we have used CHERG rules and GRADE criteria for
selection of an appropriate estimate for inclusion in the
LiST model.
Two systemic reviews by Wennerholm et al. 2009 [46]
and Sanchez-Ramos et al. 2003 [5] also analyzed the
impact of labour induction on stillbirths and perinatal
mortality. Both reviews included a total of 13 trials.
These reviews, like ours had included only those studies
in their meta-analysis that reported the impacts of labour
induction at or beyond 41 weeks of gestation. Neither of
these two reviews, however, reported a significant differ-
ence in the rate of stillbirth or perinatal mortality
between active and expectant management of post-term
pregnancy. The review by Sanchez-Ramos also included
the studies by Cardozo et al 1986 and Katz et al 1983,
while we excluded these studies from our meta-analysis
because these were both quasi-experimental studies.
These studies have also been excluded from the review
by Gulmezoglu et al. 2009 and Wennerholm et al. 2009
on basis of them being alternate allocation trials. We also
included one study by Suikkari et al. [31] that was pub-
lished as an abstract only. This study was not present in
Wennerholm review but included in both Gulmezoglu
and Sanchez-Ramos review. A study by Sahraoui et al.
published in 2005, has been included in our review, while
none of the other three reviews have included it [34].
Another recent trial by Heimstad et al. [25] published in
2007 has been included in our review and the review by
Wennerholm et al 2009, but is not present in either
Study or Subgroup
1.7.1 41 completed weeks
Chanrachkul 2003
Dyson 1987
Gelisen 2005
Hannah 1992
Heimstad 2007
NICHHD 1994
Subtotal (95% CI)
Total events
Heterogeneity: Tau² = 0.11; Chi² = 20.56, df = 5 (P = 0.0010); I² = 76%
Test for overall effect: Z = 2.03 (P = 0.04)
1.7.2 42 completed weeks
Ocon 1997
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.10; Chi² = 20.57, df = 6 (P = 0.002); I² = 71%
Test for overall effect: Z = 2.12 (P = 0.03)
Events
8
29
23
78
109
27
274
5
5
279
Total
124
152
300
1700
254
174
2704
57
57
2761
Events
4
42
74
94
132
31
377
6
6
383
Total
125
150
300
1698
254
175
2702
56
56
2758
Weight
5.1%
16.5%
15.9%
19.7%
22.2%
15.1%
94.5%
5.5%
5.5%
100.0%
M-H, Random, 95% CI
2.02 [0.62, 6.52]
0.68 [0.45, 1.03]
0.31 [0.20, 0.48]
0.83 [0.62, 1.11]
0.83 [0.69, 0.99]
0.88 [0.55, 1.40]
0.72 [0.52, 0.99]
0.82 [0.26, 2.53]
0.82 [0.26, 2.53]
0.72 [0.54, 0.98]
Induction Expectant Risk Ratio Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 5 Induction of labour versus expectant management; Outcome: macrosomia (birth weight > 4000gm).
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Page 8 of 12Gulmezoglu or Sanchez-Ramos review. We have
excluded any non-english article that was not translated
and for which the abstract did not provide adequate data.
T h es a m ea p p r o a c hw a su s e db yW e n n e r h o l me ta l .T h e
reviews by Sanchez Ramos et al. or Gulmezoglu et al. did
not exclude studies based on this criterion. However,
there were no additional studies in either of the latter
reviews that were not included in our review. Hence, it is
unlikely that we have missed out any clinical trial because
it was published in a language other than English.
Recommendations for LiST
Table 1 shows the qualitative assessment of overall
evidence regarding induction of labor at 41 weeks and
beyond. The pooled estimate from 14 randomized con-
trolled trials showed a non-significant reduction in still-
births [RR = 0.29, 95 % CI 0.06-1.38] and a significant
reduction in perinatal mortality [RR = 0.31, 95 % CI
0.11-0.88]. We graded the overall quality of evidence for
stillbirths and perinatal mortality as ‘moderate’.T h i s
assessment was based on the fact that most of the stu-
dies were conducted in developed country settings and
numbers of events were relatively few in the interven-
tion and control groups. Using CHERG rules, we
recommend a reduction in perinatal mortality (i.e. 69 %)
as a surrogate for reduction in stillbirths. The reason for
recommending perinatal mortality as surrogate for still-
births was based on the fact most of the studies do not
report disaggregated data for stillbirths but do so for
perinatal mortality. In order to further support this
assumption we pooled the data for early neonatal mor-
tality in the included studies and the results showed a
non-significant (RR = 0.37; 95% CI: 0.10 – 1.38) reduc-
tion in early neonatal mortality (data not shown). We
suggest that the main effect of IOL in the combined
outcome of ‘perinatal mortality’ could be due to still-
births. Further evidence of effectiveness of IOL at 41
weeks comes from the fact that this approach reduces
incidence of morbidities like meconium aspiration syn-
drome (RR=0.43 95% CI 0.23- 0.79) and macrosomia
(RR=0.72 95% CI 0.54-0.98).
As the number of stillbirths in the randomized trials
was relatively small, we also included observational stu-
dies in our review. Although the quality of evidence
derived from observational studies is generally considered
poor, it is worth considering data from these studies.
The, evidence from observational studies included is vari-
able, half of the studies showed a significant difference in
the rate of stillbirth and perinatal death for active versus
expectant management, thereby advocating the use of
Study or Subgroup
1.6.1 41 completed weeks
Chanrachkul 2003
Heimstad 2007
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.11, df = 1 (P = 0.74); I² = 0%
Test for overall effect: Z = 0.94 (P = 0.35)
1.6.2 42 completed weeks
Subtotal (95% CI)
Total events
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.11, df = 1 (P = 0.74); I² = 0%
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Not applicable
Events
1
5
6
0
6
Total
124
254
378
0
378
Events
0
3
3
0
3
Total
125
254
379
0
379
Weight
14.2%
85.8%
100.0%
100.0%
M-H, Fixed, 95% CI
3.02 [0.12, 73.52]
1.67 [0.40, 6.90]
1.86 [0.51, 6.76]
Not estimable
1.86 [0.51, 6.76]
Induction Expectant Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 6 Induction of labour versus expectant management Outcome: Outcome: Birth Asphyxia.
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Page 9 of 12Table 1 Quality assessment of trials of elective induction of labour versus expectant management for post-term pregnancies
Quality Assessment Summary of Findings
Directness No of events
No of
studies
(ref)
Design Limitations Consistency Generalizability
to population
of interest
Generalizability
to intervention
of interest
Intervention Control Relative Risk
(95% CI)
Mortality (Stillbirth): ‘MODERATE’ outcome specific quality
14 All RCTs; only 4 out of 14 RCTs
report estimable differences in
stillbirth between the two
groups
Small sample size in 12
studies; result statistically
insignificant; wide CI:
low precision
All studies are consistent in showing a
tendency towards reduction of stillbirth as
an outcome i.e. the direction of effect is
towards benefit
5 in developing
countries; rest in
developed
Yes 0 4 RR (fixed): 0.29
(0.06 - 1.38)
Mortality (Perinatal mortality): ‘MODERATE’ outcome specific quality
14 All RCTs; only 8 out of 14 RCTs
report estimable differences in
perinatal mortality between the
two groups
Small sample size in 12
studies
All studies are consistent in showing a
tendency towards reduction in perinatal
mortality as an outcome i.e. the direction of
effect is towards benefit
5 in developing
countries; rest in
developed
Yes 1 10 RR (fixed): 0.31
(0.11 - 0.88)
Serious morbidity (Meconium aspiration syndrome):’MODERATE’ outcome specific quality
7 All RCTs Small sample sizes in all
studies
Consistent with 5/7 studies showing
direction of benefit
3 out of 7 in
developing
countries
Yes 14 33 RR (fixed): 0.43
(0.23 - 0.79)
Serious morbidity (Birth asphyxia): ‘MODERATE’ outcome specific quality
2 RCTs Small sample sizes Both the studies show a direction towards
increased risk
1/2 in
developing
countries
Yes 6 3 RR (fixed): 1.86
(0.51 - 6.76)
Mild morbidity (Macrosomia): ‘MODERATE’ outcome specific quality
7 All RCTs Small sample sizes
except in one study
6/7 studies showing direction of benefit i.e.
consistent
2/7 in
developing
countries
Yes 279 383 RR (random): 0.72
(0.54 - 0.98)
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2routine IOL for post-term pregnancies. A large scale
study conducted in Canada by Sue-A-Quan et al. [42]
showed a significant reduction in the rate of stillbirths as
the rates of elective IOL at or beyond 41 weeks of gesta-
tion increased (p<0.001) in the years 1980 to 1995.
Another study [43] comprising of a fairly large number of
cases of prolonged gestation showed that the rate of peri-
natal mortality was significantly higher in patients in
whom spontaneous labour was awaited while no deaths
were reported in the induced women. The only large
scale study showing no difference in perinatal mortality
b e t w e e nt h et w og r o u p sw a sas t u d yb yM a l ye ta l .[ 4 1 ] .
The remaining studies had very small sample sizes, which
do not have sufficient power to detect differences in peri-
natal mortality and/or stillbirths.
Conclusions
There is a well-established increased risk of adverse peri-
natal outcome with pregnancies that extend into the post-
term period. Routine induction of labour (at or beyond
41 weeks) seems to be the likely solution for preventing
perinatal morbidity and mortality associated with post
term pregnancy. Data on stillbirths show no significant
effect of IOL post term. Using CHERG rules we propose
to use a reduction of 69% (derived from effect on perinatal
mortality) in incidence of stillbirths for inclusion in the
LiST model for the effect of induction of labour post term.
Key Messages
￿ Elective IOL for prolonged pregnancies at or beyond
41 leads to significant reduction in perinatal mortality
[RR 0.31 95 % CI 0.11-0.88] but a non-significant reduc-
tion in stillbirths [0.29, 95 % CI 0.06-1.38].
￿ There was a significant reduction of 57% in the inci-
dence of meconium aspiration syndrome (MAS) and a
non-significant impact for birth asphyxia with the use of
elective IOL post term.
￿ There was a significant 28% reduction in the inci-
dence of macrosomia (RR=0.72 95% CI 0.54-0.98) with
elective IOL.
￿ Given the association of IOL beyond 41 weeks with
reduction in perinatal deaths and assuming these are
mostly due to stillbirths, we are recommending an effect
size of 69% reduction of risk of stillbirth with IOL for
pregnancies beyond 41 weeks gestation.
Additional material
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Additional file 3: Characteristics of included studies: Observational
studies.
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